Apple eyes a patent for a watch band that maintains constant tension. Read about this and other recently published patent applications.
In this post, we take you through recent patent applications from IBM, Google, Microsoft, Apple, Intel, Medtronic, Boston Scientific, Roche, Merck, and Novartis.
IBM Seeks a Patent for Bot-based Data Collection for Detecting Phone Solicitations
US patent application 20200034743 discloses a method for answering incoming phone calls received at pre-specified phone numbers utilizing a bot, which engages in a conversation with a caller initiating an incoming phone call utilizing a voice recording that impersonates a human being. Each conversation the bot engages in is recorded, and each recorded conversation is classified as one of poison data or truthful training data based on the content. A diagram for collecting poison resilient training data for detecting/preventing unwanted phone solicitations is illustrated below.
Google Files a Patent Application Related to Taking Photos Through Visual Obstructions
US patent application 20200036908 discloses a method for removing occluding elements in a foreground of an image upon determining a visual obstruction in an initial image capture of a scene. The figures below illustrate the image capture scenario that represents the obstruction removal process.
Microsoft Seeks a Patent for Motion-restricting Wearable Safety Device
US patent application 20200029635 describes a method for preventing a user from interacting with an identified hazard and a motion-restricting system configured to restrict movement of a skeletal joint based on the sensor data received. The figure below illustrates a motion-restricting system of a wearable device that is activated based on the external sensor data.
Apple Eyes a Patent for a Watch Band That Maintains Constant Tension
US patent application 20200029660 discloses a watch band worn by a user that maintains constant tension or force by automatically changing the length to fit the user’s wrist as they move their wrist normally. The figures below illustrate a watch worn on a straight wrist of a user and its associated cross-section.
Intel Wants a Patent for Apparatus, Systems and Methods for Powering Robots
US patent application 20200031245 discloses a system for powering robots on the floor that include a conductive floor having stationary conductors positioned in a pattern and a power delivery circuit to cause adjacent conductors to have different electrical potentials and form a circuit to deliver power to the robot via contacts formed in a bottom surface of the robot. The illustration depicts a power delivery system.
Boston Scientific Seeks to Patent an AR/VR System for Use with Neuromodulation Therapy
US patent application 20200030035 discloses a system which is capable of (i) evaluating prospective implantable neurostimulator patient candidates, and (ii) determining optimal stimulation settings for already-implanted neurostimulation patients. The image below illustrates an exemplary virtual or augmented reality system.
Medtronic Wants to Patent a Denuder
US patent application 20200030120 reveals a denuder which includes a nozzle that is configured to be coupled to a source of fluid and a container body that includes a curved chamber wall forming a wash chamber. The illustration below depicts a denuder container.
Roche Aims to Patent an Automated System for Processing Particles
US patent application 20200033240 describes an automated biological particle processing system that includes a rotatable vessel about a longitudinal axis, an upper portion having a top opening for receiving the liquid comprising the particles, a lower portion for holding the liquid while the rotatable vessel is resting, and an intermediate portion with a lateral collection chamber for holding the liquid while the rotatable vessel is rotating. The figure below depicts the automated system.
Merck Pursues a Patent on an Avelumab Composition
US patent application 20200031933 discloses an avelumab composition with elevated deamidation levels for treating disorders in which the interaction between PD-1 and PD-L1 are detrimental.
Novartis Seeks to Patent a Combinational Therapy for Cancer
US patent application 20200030442 reveals a combinational therapy for treating cancer comprising an immunomodulator and a second therapeutic agent which is 1) a protein kinase C (PKC) inhibitor, 2) a heat shock protein 90 (HSP90) inhibitor, 3) an inhibitor of a phosphoinositide 3-kinase (PI3K) and/or target of rapamycin (mTOR).